Advertisement
Home »

#VisualAbstract: Finotonlimab with chemotherapy increases overall survival in recurrent or metastatic head and neck cancer

Jul 13, 2024

ABOUT THE EXPERTS

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement